IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 278.45M | 248.19M | 274.61M | 293.99M | 242.68M |
| Total Depreciation and Amortization | 37.68M | 38.72M | 36.63M | 35.77M | 34.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.87M | 51.87M | 111.05M | 19.84M | 21.91M |
| Change in Net Operating Assets | -89.75M | 16.98M | -19.95M | -163.86M | -60.69M |
| Cash from Operations | 266.25M | 355.76M | 402.34M | 185.74M | 237.96M |
| Capital Expenditure | -31.98M | -29.43M | -31.11M | -34.10M | -30.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.56M | 1.30M | -13.76M | 474.00K | 416.00K |
| Cash from Investing | -33.54M | -28.13M | -44.87M | -33.63M | -29.61M |
| Total Debt Issued | 132.00M | 193.00M | -124.00M | 259.50M | 69.50M |
| Total Debt Repaid | -- | -325.00M | 0.00 | -103.39M | -- |
| Issuance of Common Stock | 18.16M | 17.87M | 50.97M | 17.33M | 7.19M |
| Repurchase of Common Stock | -361.59M | -237.83M | -240.28M | -339.08M | -407.01M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.74M | -- | -- | -- |
| Cash from Financing | -211.43M | -355.70M | -313.31M | -165.63M | -330.32M |
| Foreign Exchange rate Adjustments | -816.00K | -24.00K | -587.00K | 14.14M | -2.33M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.46M | -28.10M | 43.57M | 624.00K | -124.30M |